Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / Mar / Also in the News… (2)
Cornea Glaucoma Retina

Also in the News…

The Ophthalmologist brings you the top news stories and studies of the week

3/28/2025 2 min read

Share

0325-000-Online-Week4-InArticle.png

Michael Barera, CC BY-SA 4.0 <https://creativecommons.org/licenses/by-sa/4.0>, via Wikimedia Commons

From the launch of a new cloud-based lens design system, to a combined POAG diagnostic approach, these are the news stories and studies that caught our attention this week…

Arise available. Bausch + Lomb’s cloud-based orthokeratology lens design system, Arise, is now available in the UK, Europe, and US. The company reports that Arise uses advanced algorithms to “seamlessly sync directly with topographers to create precise lens designs in seconds to treat myopia.” Link

VEVYE Access for All program. Pharmaceutical company Harrow (Nashville, TN, USA) has launched its VEVYE Access for All program. The program enables physicians to prescribe VEVYE (cyclosporine ophthalmic solution) 0.1 percent without prior authorization, and is delivered to patients through its national mail-order pharmacy partner, PhilRx. Link

Expanded indication for ILUVIEN. ANI Pharmaceuticals (Baudette, MN, USA) has announced that ILUVIEN (fluocinolone acetonide intravitreal implant) has received US FDA approval for the treatment of chronic on-infectious uveitis of the posterior segment (NIU-PS) in addition to its current indication for diabetic macular edema (DME). Link

Two-pronged POAG approach. An Ophthalmic Research study has introduced a new diagnostic approach for early primary open-angle glaucoma (POAG) based on steady-state pattern electroretinogram (ssPERG) and optical coherence tomography (OCT) parameters. The study found that PERGratio (a measure from ssPERG), combined with the 7 o’clock circumpapillary retinal nerve fiber layer (cpRNFL) thickness from OCT, provided the highest diagnostic accuracy, improving early detection of retinal ganglion cell (RGC) dysfunction. Supporting the dysfunction-preceding-death hypothesis, the findings suggest this dual-modality approach could allow for earlier glaucoma diagnosis, though implementation challenges remain due to logistic regression complexities. Link

Pig’s eye platform. A US-Canada research team has developed a method to generate retinal organoids (ROs) from porcine stem cells (piPSCs), providing a preclinical model for studying retinal degenerative diseases (RDDs). As the pig retina closely resembles the human retina, these photoreceptor-rich organoids can mimic human retinal development at the molecular level, offering a more reliable testing platform for future transplantation research, according to the authors. Link

Major disparities in POAG monitoring. A Northwestern University and University of Michigan Kellogg Eye Center study has revealed significant disparities in glaucoma care, showing that race, income, and geographic location impact adherence to optic nerve monitoring guidelines for primary open-angle glaucoma (POAG). To address these disparities, the researchers recommend expanding teleophthalmology, increasing access to home-based monitoring, and implementing targeted screening programs to ensure equitable glaucoma care across the US. Link

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: